肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色

2016-05-30 美国临床肿瘤学会 March 21, 2016 as 10.1200/JCO.2015.65.8609

早期乳腺癌辅助疗法

2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色 

中文标题：

2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色

英文标题：

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations

发布机构：

美国临床肿瘤学会

发布日期：

2016-05-30

简要介绍：

2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色 

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色)] GetToolGuiderByIdResponse(projectId=1, id=3266d1c001191397, title=2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色, enTitle=Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations, guiderFrom=March 21, 2016 as 10.1200/JCO.2015.65.8609, authorId=null, author=, summary=2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色 , cover=, journalId=null, articlesId=null, associationId=8, associationName=美国临床肿瘤学会, associationIntro=美国临床肿瘤学会（ASCO，American Society of Clinical Oncology）是一个成立于1964年的非营利性组织，总目标是改善肿瘤的监护与预防。目前已有27000名肿瘤科医师加入了ASCO，分属各个肿瘤专科和亚专科。会员包括在肿瘤治疗各个层次的医师和卫生保健专业人员。ASCO由一个有19名成员的当选董事会管理，该学会的大部分业务是由志愿为学会项目花费时间和出力的ASCO会员组成的各种委员会处理的。患者支持团体的领导也经常活跃于ASCO委员会中。目前有22个由ASCO的全职人员管理和支持的委员会。, copyright=0, guiderPublishedTime=Mon May 30 22:39:20 CST 2016, originalUrl=, linkOutUrl=, content=2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色 , tagList=[TagDto(tagId=9593, tagName=早期乳腺癌), TagDto(tagId=66080, tagName=辅助疗法)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=null, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3026, appHits=53, showAppHits=0, pcHits=2308, showPcHits=820, likes=223, shares=1, comments=3, approvalStatus=1, publishedTime=Mon May 30 14:39:20 CST 2016, publishedTimeString=2016-05-30, pcVisible=1, appVisible=1, editorId=5295946, editor=kelly, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=kelly, createdTime=Mon May 30 14:39:20 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:59:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色)])
2016 ASCO指南推荐：早期，可手术的乳腺癌辅助疗法决策中患者和疾病因素的角色
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1001684, encodeId=ed7e100168476, content=学习了，好好看看研究, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:13:51 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103061, encodeId=79a110306147, content=看看挺不错的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160417/IMG5713A450556263030.jpg, createdBy=b2e11713968, createdName=永恒光辉, createdTime=Wed Aug 24 14:28:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95626, encodeId=dda79562610, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2021-07-22 cyjen

    学习了，好好看看研究

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1001684, encodeId=ed7e100168476, content=学习了，好好看看研究, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:13:51 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103061, encodeId=79a110306147, content=看看挺不错的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160417/IMG5713A450556263030.jpg, createdBy=b2e11713968, createdName=永恒光辉, createdTime=Wed Aug 24 14:28:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95626, encodeId=dda79562610, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2016-08-24 永恒光辉

    看看挺不错的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1001684, encodeId=ed7e100168476, content=学习了，好好看看研究, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79b75554426, createdName=cyjen, createdTime=Thu Jul 22 14:13:51 CST 2021, time=2021-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=103061, encodeId=79a110306147, content=看看挺不错的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160417/IMG5713A450556263030.jpg, createdBy=b2e11713968, createdName=永恒光辉, createdTime=Wed Aug 24 14:28:00 CST 2016, time=2016-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95626, encodeId=dda79562610, content=下载啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 03 06:00:00 CST 2016, time=2016-08-03, status=1, ipAttribution=)]
    2016-08-03 1dd8c52fm63(暂无匿称)

    下载啦！

    0